• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

深度学习框架结合分子影像和蛋白质结构表示,为疼痛候选药物的鉴定提供了依据。

A deep learning framework combining molecular image and protein structural representations identifies candidate drugs for pain.

机构信息

Cleveland Clinic Genome Center, Lerner Research Institute, Cleveland Clinic, Cleveland, OH 44195, USA; Department of Computer Science, Kent State University, Kent, OH 44242, USA; Genomic Medicine Institute, Lerner Research Institute, Cleveland Clinic, Cleveland, OH 44195, USA.

Genomic Medicine Institute, Lerner Research Institute, Cleveland Clinic, Cleveland, OH 44195, USA.

出版信息

Cell Rep Methods. 2024 Oct 21;4(10):100865. doi: 10.1016/j.crmeth.2024.100865. Epub 2024 Sep 27.

DOI:10.1016/j.crmeth.2024.100865
PMID:39341201
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11573792/
Abstract

Artificial intelligence (AI) and deep learning technologies hold promise for identifying effective drugs for human diseases, including pain. Here, we present an interpretable deep-learning-based ligand image- and receptor's three-dimensional (3D)-structure-aware framework to predict compound-protein interactions (LISA-CPI). LISA-CPI integrates an unsupervised deep-learning-based molecular image representation (ImageMol) of ligands and an advanced AlphaFold2-based algorithm (Evoformer). We demonstrated that LISA-CPI achieved ∼20% improvement in the average mean absolute error (MAE) compared to state-of-the-art models on experimental CPIs connecting 104,969 ligands and 33 G-protein-coupled receptors (GPCRs). Using LISA-CPI, we prioritized potential repurposable drugs (e.g., methylergometrine) and identified candidate gut-microbiota-derived metabolites (e.g., citicoline) for potential treatment of pain via specifically targeting human GPCRs. In summary, we presented that the integration of molecular image and protein 3D structural representations using a deep learning framework offers a powerful computational drug discovery tool for treating pain and other complex diseases if broadly applied.

摘要

人工智能(AI)和深度学习技术有望为人类疾病(包括疼痛)的有效药物的研发提供支持。在这里,我们提出了一种基于可解释的深度学习的配体图像和受体三维(3D)结构感知框架,用于预测化合物-蛋白相互作用(LISA-CPI)。LISA-CPI 整合了一种无监督的基于深度学习的配体分子图像表示(ImageMol)和先进的基于 AlphaFold2 的算法(Evoformer)。我们证明,与连接 104,969 个配体和 33 个 G 蛋白偶联受体(GPCR)的实验 CPIs 的最先进模型相比,LISA-CPI 在平均均方误差(MAE)方面提高了约 20%。使用 LISA-CPI,我们对潜在的可重新利用药物(如甲基麦角新碱)进行了优先级排序,并确定了候选的肠道微生物衍生代谢物(如胞磷胆碱),通过专门针对人类 GPCR,用于潜在的疼痛治疗。总之,如果广泛应用,利用深度学习框架整合分子图像和蛋白质 3D 结构表示为治疗疼痛和其他复杂疾病提供了一种强大的计算药物发现工具。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f793/11573792/11bcd9dfd511/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f793/11573792/4325fbb3093c/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f793/11573792/a060fc9c649f/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f793/11573792/9f3b6a293216/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f793/11573792/17e08eb4defa/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f793/11573792/0db268d8963d/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f793/11573792/11bcd9dfd511/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f793/11573792/4325fbb3093c/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f793/11573792/a060fc9c649f/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f793/11573792/9f3b6a293216/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f793/11573792/17e08eb4defa/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f793/11573792/0db268d8963d/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f793/11573792/11bcd9dfd511/gr5.jpg

相似文献

1
A deep learning framework combining molecular image and protein structural representations identifies candidate drugs for pain.深度学习框架结合分子影像和蛋白质结构表示,为疼痛候选药物的鉴定提供了依据。
Cell Rep Methods. 2024 Oct 21;4(10):100865. doi: 10.1016/j.crmeth.2024.100865. Epub 2024 Sep 27.
2
Machine learning and AI-based approaches for bioactive ligand discovery and GPCR-ligand recognition.基于机器学习和人工智能的生物活性配体发现和 GPCR 配体识别方法。
Methods. 2020 Aug 1;180:89-110. doi: 10.1016/j.ymeth.2020.06.016. Epub 2020 Jul 6.
3
WDL-RF: predicting bioactivities of ligand molecules acting with G protein-coupled receptors by combining weighted deep learning and random forest.WDL-RF:通过结合加权深度学习和随机森林预测与 G 蛋白偶联受体相互作用的配体分子的生物活性。
Bioinformatics. 2018 Jul 1;34(13):2271-2282. doi: 10.1093/bioinformatics/bty070.
4
Reliability of AlphaFold2 Models in Virtual Drug Screening: A Focus on Selected Class A GPCRs.AlphaFold2 模型在虚拟药物筛选中的可靠性:关注选定的 A 类 GPCR 。
Int J Mol Sci. 2024 Sep 21;25(18):10139. doi: 10.3390/ijms251810139.
5
The application of artificial intelligence to accelerate G protein-coupled receptor drug discovery.人工智能在 G 蛋白偶联受体药物发现中的应用。
Br J Pharmacol. 2024 Jul;181(14):2371-2384. doi: 10.1111/bph.16140. Epub 2023 May 26.
6
Accurate prediction of molecular targets using a self-supervised image representation learning framework.使用自监督图像表示学习框架准确预测分子靶点。
Res Sq. 2022 Apr 7:rs.3.rs-1477870. doi: 10.21203/rs.3.rs-1477870/v1.
7
A Machine Learning Approach for the Discovery of Ligand-Specific Functional Mechanisms of GPCRs.一种用于发现 GPCR 配体特异性功能机制的机器学习方法。
Molecules. 2019 Jun 2;24(11):2097. doi: 10.3390/molecules24112097.
8
Quantitative and systems pharmacology 2. In silico polypharmacology of G protein-coupled receptor ligands via network-based approaches.定量和系统药理学 2. 通过基于网络的方法研究 G 蛋白偶联受体配体的多药理学。
Pharmacol Res. 2018 Mar;129:400-413. doi: 10.1016/j.phrs.2017.11.005. Epub 2017 Nov 10.
9
Artificial intelligence to deep learning: machine intelligence approach for drug discovery.人工智能到深度学习:药物发现的机器智能方法。
Mol Divers. 2021 Aug;25(3):1315-1360. doi: 10.1007/s11030-021-10217-3. Epub 2021 Apr 12.
10
A Machine Learning Algorithm Suggests Repurposing Opportunities for Targeting Selected GPCRs.机器学习算法提示了针对特定 GPCR 靶向的再利用机会。
Int J Mol Sci. 2024 Sep 23;25(18):10230. doi: 10.3390/ijms251810230.

引用本文的文献

1
A roadmap for artificial intelligence in pain medicine: current status, opportunities, and requirements.疼痛医学中人工智能的路线图:现状、机遇与要求。
Curr Opin Anaesthesiol. 2025 Apr 24. doi: 10.1097/ACO.0000000000001508.

本文引用的文献

1
AlphaFold2 structures guide prospective ligand discovery.AlphaFold2 结构指导有前景的配体发现。
Science. 2024 Jun 21;384(6702):eadn6354. doi: 10.1126/science.adn6354.
2
Accurate structure prediction of biomolecular interactions with AlphaFold 3.利用 AlphaFold 3 进行生物分子相互作用的精确结构预测。
Nature. 2024 Jun;630(8016):493-500. doi: 10.1038/s41586-024-07487-w. Epub 2024 May 8.
3
Systematic characterization of multi-omics landscape between gut microbial metabolites and GPCRome in Alzheimer's disease.系统性分析阿尔茨海默病中肠道微生物代谢物与 G 蛋白偶联受体组之间的多组学特征。
Cell Rep. 2024 May 28;43(5):114128. doi: 10.1016/j.celrep.2024.114128. Epub 2024 Apr 21.
4
Computational drug development for membrane protein targets.计算药物研发用于膜蛋白靶标。
Nat Biotechnol. 2024 Feb;42(2):229-242. doi: 10.1038/s41587-023-01987-2. Epub 2024 Feb 15.
5
Distinct signatures of gut microbiota and metabolites in different types of diabetes: a population-based cross-sectional study.不同类型糖尿病中肠道微生物群和代谢物的独特特征:一项基于人群的横断面研究。
EClinicalMedicine. 2023 Aug 3;62:102132. doi: 10.1016/j.eclinm.2023.102132. eCollection 2023 Aug.
6
Gut microbiome composition may be an indicator of preclinical Alzheimer's disease.肠道微生物组的组成可能是临床前阿尔茨海默病的一个指标。
Sci Transl Med. 2023 Jun 14;15(700):eabo2984. doi: 10.1126/scitranslmed.abo2984.
7
The Association between Dysbiosis and Neurological Conditions Often Manifesting with Chronic Pain.生态失调与常伴有慢性疼痛的神经疾病之间的关联。
Biomedicines. 2023 Mar 1;11(3):748. doi: 10.3390/biomedicines11030748.
8
Gut microbiota and its metabolites in depression: from pathogenesis to treatment.肠道微生物群及其代谢物与抑郁症:从发病机制到治疗。
EBioMedicine. 2023 Apr;90:104527. doi: 10.1016/j.ebiom.2023.104527. Epub 2023 Mar 22.
9
Butyrate's role in human health and the current progress towards its clinical application to treat gastrointestinal disease.丁酸盐在人类健康中的作用及将其临床应用于治疗胃肠道疾病的最新进展。
Clin Nutr. 2023 Feb;42(2):61-75. doi: 10.1016/j.clnu.2022.10.024. Epub 2022 Nov 2.
10
NAD metabolism in peripheral neuropathic pain.外周神经性疼痛中的NAD代谢
Neurochem Int. 2022 Dec;161:105435. doi: 10.1016/j.neuint.2022.105435. Epub 2022 Oct 21.